12:12 PM EST - Oncolytics Biotech Inc : Announced an update regarding the status of its GOBLET Phase 1/2 study, including timing for the release of certain clinical data. It also declared that it will receive the final payment under its grant from the Pancreatic Cancer Action Network later this quarter, following the completion of certain activities in Cohort 5 of the study. Oncolytics Biotech Inc
shares N.ONCY are trading up $0.05 at $0.53.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7673561340291745
